Deals to Restrain Generic Drugs Face a Ban in Health Care Bill
Tuesday, January 12, 2010 - 23:49
in Mathematics & Economics
A group of House lawmakers plans to ask Congress to block deals in which they say makers of name-brand drugs directly or indirectly pay generic makers to delay competition from cheaper generic alternatives.